CUL4B and rheumatoid arthritis: Therefore, we propose a hypothesis that HQC may inhibit the pathogenesis of RA through the CUL4B/Wnt pathway, and HQC may be an effective RA therapeutic drug dependent on the CUL4B/Wnt pathway.